Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kendall

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Diabetes Care|December 24, 2005
Thiazolidinediones: the case for early useDavid M Kendall
Journal of Clinical Hypertension (Greenwich, Conn.)|April 7, 2011
Blood pressure targets in diabetes: is this the time for change?David M Kendall
Metabolic Syndrome and Related Disorders|March 29, 2008
Response to bellDavid M Kendall
Endocrinology and Metabolism Clinics of North America|March 9, 2005
The dyslipidemia of diabetes mellitus: giving triglycerides and high-density lipoprotein cholesterol a higher priority?David M Kendall
ACP Journal Club|May 3, 2005
Review: insulin monotherapy and insulin combined with oral hypoglycemic agents provide similar glycemic controlDavid M Kendall
ACP Journal Club|May 3, 2005
Review: short-acting insulin analogues reduce glycosylated hemoglobin more than regular human insulin but only in adults with type 1 diabetesDavid M Kendall
Journal of Clinical Hypertension (Greenwich, Conn.)|April 7, 2011
Blood pressure targets in diabetes: is this the time for change?--PRO (Rebuttal)David M Kendall
Metabolic Syndrome and Related Disorders|March 29, 2008
The Truth about Lipid Effects of the ThiazolidinedionesDavid M Kendall
Clinical Chemistry|September 17, 2010
Hemoglobin A1c to diagnose diabetes: why the controversy over adding a new tool?M Sue Kirkman, David M Kendall
The American Journal of Managed Care|January 4, 2003
The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistanceDavid M Kendall, Anne Peters Harmel
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Diabetes Care|December 24, 2005
Thiazolidinediones: the case for early useDavid M Kendall
Journal of Clinical Hypertension (Greenwich, Conn.)|April 7, 2011
Blood pressure targets in diabetes: is this the time for change?David M Kendall
Metabolic Syndrome and Related Disorders|March 29, 2008
Response to bellDavid M Kendall
Endocrinology and Metabolism Clinics of North America|March 9, 2005
The dyslipidemia of diabetes mellitus: giving triglycerides and high-density lipoprotein cholesterol a higher priority?David M Kendall
ACP Journal Club|May 3, 2005
Review: insulin monotherapy and insulin combined with oral hypoglycemic agents provide similar glycemic controlDavid M Kendall
ACP Journal Club|May 3, 2005
Review: short-acting insulin analogues reduce glycosylated hemoglobin more than regular human insulin but only in adults with type 1 diabetesDavid M Kendall
Journal of Clinical Hypertension (Greenwich, Conn.)|April 7, 2011
Blood pressure targets in diabetes: is this the time for change?--PRO (Rebuttal)David M Kendall
Metabolic Syndrome and Related Disorders|March 29, 2008
The Truth about Lipid Effects of the ThiazolidinedionesDavid M Kendall
Clinical Chemistry|September 17, 2010
Hemoglobin A1c to diagnose diabetes: why the controversy over adding a new tool?M Sue Kirkman, David M Kendall
The American Journal of Managed Care|January 4, 2003
The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistanceDavid M Kendall, Anne Peters Harmel
Pageof 6